Stephan W. Jahn
Graz, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 28 publications
Clinical Significance and Therapeutic Potential of Long Non-Coding RNA H19 in Soft Tissue Sarcoma.
Journal: Cancer medicine
Published: January 15, 2025
HER2 and HER3 expression during neoadjuvant treatment of HER2-negative early breast cancer: potential for biomarker-driven sequencing of T-DXd and HER3-DXd.
Journal: Cancer communications (London, England)
Published: August 01, 2024
TERT Promoter Mutation c.-124C>T Commonly Occurs in Low-Grade Fibromatosis-like Metaplastic Breast Carcinoma.
Journal: Archives of pathology & laboratory medicine
Published: November 28, 2022
Consequences of somatic mutations of GIRK1 detected in primary malign tumors on expression and function of G-protein activated, inwardly rectifying, K+ channels.
Journal: Frontiers in oncology
Published: July 20, 2022
Independent validation of stromal uPA in ABCSG-08: Level 1b evidence for the prognostic value of uPA immunohistochemistry.
Journal: Breast (Edinburgh, Scotland)
Published: April 07, 2022
ALYREF, a novel factor involved in breast carcinogenesis, acts through transcriptional and post-transcriptional mechanisms selectively regulating the short NEAT1 isoform.
Journal: Cellular and molecular life sciences : CMLS
Published: December 01, 2021
Sensitive and robust liquid biopsy-based detection of PIK3CA mutations in hormone-receptor-positive metastatic breast cancer patients.
Journal: British journal of cancer
Published: February 24, 2021
Digital Pathology: Advantages, Limitations and Emerging Perspectives.
Journal: Journal of clinical medicine
Published: October 08, 2020
Profiling of circulating tumor DNA and tumor tissue for treatment selection in patients with advanced and refractory carcinoma: a prospective, two-stage phase II Individualized Cancer Treatment trial.
Journal: Therapeutic advances in medical oncology
Published: July 28, 2020
Clinically high-risk breast cancer displays markedly discordant molecular risk predictions between the MammaPrint and EndoPredict tests.
Journal: British journal of cancer
Published: October 25, 2019
GIRK1 triggers multiple cancer-related pathways in the benign mammary epithelial cell line MCF10A.
Journal: Scientific reports
Published: July 09, 2019
Stromal coexpression of uPA/PAI-1 protein predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer.
Journal: Breast (Edinburgh, Scotland)
Published: January 09, 2019
Last Updated: 09/26/2026